Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Northern Trust Corporation Common Stock (NTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Northern Trust Corporation Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while Northern Trust Corporation Common Stock trades at $162.48 (market cap $30.63B). The key difference: Northern Trust Corporation Common Stock is far larger — about 3.5× Kymera Therapeutics Inc. Common Stock's market cap, and Northern Trust Corporation Common Stock pays a 1.96% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Northern Trust Corporation Common Stock for 0 Days on average.
| KYMR | NTRS | |
|---|---|---|
Market Cap | $8.87B | $30.63B |
Volume | 779,107 | 964,550 |
Sector | Health | Financials |
52-Week High | $127.31 | $191.47 |
52-Week Low | $55.80 | $122.72 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | -$5.35B |
Dividend Yield | — | 1.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Northern Trust Corporation Common Stock
Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →
